Instruction for self-administration is mentioned in the Package Leaflet. The needle protection system of the Arixtra pre-filled syringes have been designed with a. Please read this leaflet carefully before you start using Arixtra. This leaflet answers some common . package insert in each Arixtra carton. Mylan manufactures ARIXTRA®* (fondaparinux sodium) Injection, Solution ( Arixtra) in strengths of 25 mg05 mL 5 mgmL5 Category: Human Prescription Drug.
|Published (Last):||8 May 2006|
|PDF File Size:||19.80 Mb|
|ePub File Size:||20.37 Mb|
|Price:||Free* [*Free Regsitration Required]|
Treatment and prevention of heparin-induced thrombocytopenia: The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria.
Fondaparinux (Arixtra) | – A Hematology Oncology Wiki
While low-molecular weight heparins LMWH can also cause HIT, the incidence is much lower and appears to be related, in part, to the molecular weight.
Please enter text to search. Explanation The use of anticoagulants, such as unfractionated heparin UFH and low-molecular weight heparin LMWH have significantly improved patient oriented outcomes for medical conditions related to thrombotic events. For example, it is known that packae heparin use, especially beyond 4 days of treatment, is known to have a greater risk for causing HIT when compared to LMWH dalteparin, enoxaparin, and tinzaparin.
Antibodies to macromolecular platelet factor 4-heparin packae in heparin-induced thrombocytopenia: The use of anticoagulants, such as unfractionated heparin UFH and low-molecular weight heparin LMWH have significantly improved patient oriented outcomes for medical conditions related to thrombotic events.
Linkins LA et al.
As noted above, the length of the chain which influences the molecular weight contributes, in part, to heparin’s arixttra to bind to PF4 that triggers the immune mediated response seen in HIT.
There are number of risk factors associated with increasing the chance for a patient to develop HIT, one of which is the type of anticoagulant used.
Fondaparinux Arixtra is an anticoagulant that shares the same pentasaccharide sequence as UFH and LMWH for the binding to antithrombin, however it has no extra pwckage and thus, is not considered a heparin product.
About Us Disclaimer Contact Us. The reference to the chain is related to the part of the heparin molecule attached to the pentasaccharide sequence that is used in binding to antithrombin when exerting its antithrombotic effect.
Arixtra | South Africa Drug Approvals | Medicines Control Council |
It is also packave noting that some patients with HIT have been shown to have platelet recovery with fondaparinux administration. Research Triangle Park, NC.
Treatment and Prevention of Heparin Induced Thrombocytopenia: The incidence of HIT is greatest in unfractionated heparin use beyond 4 days at therapeutic doses. An evaluation of the molecular weights among the heparin related medications reveals that UFH’s molecular weight ranges from 3, to 30, daltons whereas, the LMWH range from 2, arixrta 10, daltons.
While the use of heparin based anticoagulants have improved patient oriented outcomes in patients with thrombosis related packaeg conditions, they paradoxically are also known to put some patients at risk for developing the life threatening thrombosis called heparin induced thrombocytopenia HIT.
However, they are also known to cause clinically relevant side effects, or adverse drug events, such as bleeding including hemorrhagic stroke, gastrointestinal bleeding, osteoporosis long-term usepriapism, and hyperkalemia from inhibition of aldosterone synthesis.
However, the longer the use especially if used at therapeutic doses the greater the incidence of HIT.